Translating research into clinical applications
The COVID-19 pandemic has shown that conducting strong translational research is key to combating the coronavirus. By leveraging cutting edge laboratory techniques to study patient samples, translational research quickly pivots laboratory discoveries into new therapies for patients, in a process known as the bench-to-bedside approach. Luxembourg has established excellent transversal and translational research, spanning several research topics and disease areas and integrating the results to provide holistic and meaningful insights that can tangibly improve clinical outcomes for patients.
Clinical Data Manager - MV0121
The Clinical Data Manager will join the LIH’s Competence Center for Methodology and Statistics (CCMS). Within the clinical research hub of the Department of Population Health, the CCMS provides methodological support in statistical planning as well as analysis & data handling for various laboratories and research groups. It also offers training in statistics and support in writing papers.
International prize “Prix du Fonds Léon et Henri Fredericq” awarded to LIH researcher
Dr Andy Chevigné, Group Leader of the Immuno-Pharmacology and Interactomics research group at the LIH Department of Infection and Immunity (DII), was rewarded for his outstanding contribution to the fields of allergology and molecular pharmacology through the bestowal of the “Prix du Fonds Léon et Henri Fredericq” by the Royal Academy of Science, Letters and Fine Arts of Belgium.
Spontaneous application 2021
No Job fitting your profile right now ? this link is for you ! Feel free to send us your application!
Post-Doctoral Researcher in biomonitoring of human exposure to pollutants - BA0121
The Human Biomonitoring Research Unit (HBRU) is specialized in the assessment of human exposure to pollutants and on the study of exposure-associated health outcomes. Research activities rely on both animal experimentation and human volunteers within epidemiological studies. The laboratory is equipped with up-to-date analytical equipment mainly consisting in CG-MS/MS and UHPLC-MS/MS).
Post-doctoral position in pharmacogenomics for glioma - SN1220
To be part of the NORLUX Neuro-Oncology Laboratory (Group leaders: Prof Simone Niclou and Dr. Anna Golebiewska within the Department of Oncology at the LIH, we are currently looking for a Postdoctoral Fellow.
Post-doctoral position in computational biology of glioma - SN1220
To be part of the NORLUX Neuro-Oncology laboratory (Group leaders: Prof Simone Niclou and Dr. Anna Golebiewska) within the Department of Oncology at the LIH, we are currently looking for a Postdoctoral Fellow.
[Press release] New insights into Glioblastoma invasiveness
Researchers from the NORLUX Neuro-Oncology Laboratory at the LIH Department of Oncology (DONC) explored the molecular mechanisms responsible for the ability of Glioblastoma (GBM) to infiltrate and spread to healthy brain tissue. They brought forward the novel role of protein ZFAND3 in promoting the transcription of several genes that stimulate the invasion of GBM cells in the surrounding parenchyma, the functional tissue in the brain. The findings, which carry significant implications for the development of novel therapeutic strategies against GBM, were published in the international journal Nature Communications.
Cross-border collaborations to improve cancer treatment
On December 9th, Medical & Bio Decision (MBD) announced the setup of a joint laboratory for precision medicine tailored to cancer patients, in collaboration with the Luxembourg Institute of Health (LIH) and the Integrated Biobank of Luxembourg (IBBL).